AI Science Tracker

University of Pittsburgh

2 discoveries from 2024

Discoveries

SLIDE uncovers a keratinocyte-centered signal in systemic sclerosis

An interpretable machine-learning analysis of multi-omic systemic-sclerosis data identified an unexplored keratinocyte-centered signature, validated by protein staining, and a previously unreported interaction between myeloid-cell and fibroblast states and macrophage HLA signaling. The same study also analyzed CD4 T-cell clonal expansion, but this record treats the paper's disease-mechanism findings as one discovery.

Technology: SLIDE (Significant Latent Factor Interaction Discovery and Exploration)

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

Result, AI contribution and limits

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

  • Publication status: Peer-reviewed paper
  • Test type: direct test
  • Tested: An interpretable machine-learning analysis of multi-omic systemic-sclerosis data identified an unexplored keratinocyte-centered signature, validated by protein staining, and a previously unreported interaction between myeloid-cell and fibroblast states and macrophage HLA signaling.
  • Still unknown: The paper reports computationally identified relationships and validation of one signature by protein staining; these findings do not by themselves establish causal mechanisms or clinical utility.
  • AI role: SLIDE integrated single-cell and spatial multi-omic data, identified interacting latent factors associated with systemic-sclerosis disease severity, and surfaced candidate mechanisms; the keratinocyte signal was checked with protein staining by the study team.

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC11588359/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review scope and date are not recorded; source checked does not establish full-text review.

Citations: in the top 10% of works of the same type, year and subfield (OpenAlex work metrics, 37 citations; as of 15 Nov 2026). Attention, not a measure of correctness; not part of the score.

Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Follow-up and relationships

No follow-up recorded; this is not a claim that no follow-up exists.

Follow-up review scope and date are not recorded.

No source-supported relationships recorded.

Open the interactive profile for the timeline, or browse all organizations and model families.